Login

Creating, facilitating, and promoting sustainable Health Technology Assessment (HTA) cooperation in Europe

Custom icon
Early Dialogues

Custom icon
Submission & Methodology

Custom icon
Assessments

Custom icon
National Implementation

PTJA06 – “Polatuzumab vedotin in combination with bendamustine and rituximab for treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL)” final project plan now available.

By admin  /  November 22, 2019
PTJA06 – “Polatuzumab vedotin in combination with bendamustine and rituximab for treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL)” final project plan now available.

OTCA17 – Final Assessment Report and related documents now available

By admin  /  November 22, 2019
OTCA17 – Final Assessment Report and related documents now available

OTCA23 Final Project Plan and related documents now available

By admin  /  November 21, 2019
OTCA23 Final Project Plan and related documents now available

PTJA08 – “Siponimod for the treatment of adult patients with secondary progressive multiple sclerosis (SPMS) with active disease evidenced by relapses or imaging features of inflammatory activity” project plan now available.

By admin  /  November 20, 2019
PTJA08 – “Siponimod for the treatment of adult patients with secondary progressive multiple sclerosis (SPMS) with active disease evidenced by relapses or imaging features of inflammatory activity” project plan now available.

OCTA20 Final Assessment Report is now available.

By admin  /  November 13, 2019
OCTA20 Final Assessment Report is now available.

Services

Assessments

Tools

Have Questions? Check our FAQ